In a human breast cancer xenograft model, the inhibition of glucocorticoid receptor signaling reversed the glucocorticoid-induced chemotherapy resistance,10 in line with our results, where the inhibition of the glucocorticoid receptor partially reversed the dexamethasone-induced gemcitabine resistance. This evidence concerns the gene NR3C1 and breast carcinoma.